Strategie di combinazione nella terapia del melanoma

Translated title of the contribution: Combination strategies in melanoma therapy

Francesco Spagnolo

Research output: Contribution to journalArticlepeer-review

Abstract

Immune checkpoint inhibitors led to major advances in melanoma therapy, and pembrolizumab (anti-PD-1 monoclonal antibody) is now a new standard of treatment for advanced melanoma. The aim of this work was to discuss, on the basis of planned or ongoing clinical trials, future perspectives to improve the efficacy of pembrolizumab, such as combination regimens with other immunotherapies or targeted therapies.

Translated title of the contributionCombination strategies in melanoma therapy
Original languageItalian
Pages (from-to)503-507
Number of pages5
JournalRecenti Progressi in Medicina
Volume108
Issue number12
Publication statusPublished - Dec 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Combination strategies in melanoma therapy'. Together they form a unique fingerprint.

Cite this